- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03520283
Systems Support Mapping in Guiding Self-Management in Stage I-III Colorectal Cancer Survivors
Use of Systems Support Mapping to Guide Patient-Driven Self-Management in Rural and Urban Cancer Survivors
Study Overview
Status
Conditions
- Cancer Survivor
- Stage III Colorectal Cancer AJCC v8
- Stage IIIA Colorectal Cancer AJCC v8
- Stage IIIB Colorectal Cancer AJCC v8
- Stage IIIC Colorectal Cancer AJCC v8
- Stage I Colorectal Cancer AJCC v8
- Stage II Colorectal Cancer AJCC v8
- Stage IIA Colorectal Cancer AJCC v8
- Stage IIB Colorectal Cancer AJCC v8
- Stage IIC Colorectal Cancer AJCC v8
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVES:
I. To evaluate the feasibility of the systems support mapping (MAP) intervention in colorectal cancer survivors, as characterized by enrollment, intervention adherence, and retention rates.
SECONDARY OBJECTIVES:
I. To evaluate intervention acceptability as characterized by participant ratings.
II. To describe outcome variability to inform future studies. III. To identify multi-level contextual factors influencing self-management (SM).
IV. To qualitatively assess feasibility, acceptability using semi-structured interviews.
V. To examine how study results vary by rural-urban context.
OUTLINE:
Participants complete MAP in-clinic over 60-90 minutes.
After completion of study, participants are followed-up for up to 2 weeks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosed with stage I-III colorectal cancer
- Within 2 years of completing active treatment for colorectal cancer
- Cognitively able to complete interviews as judged by the study team
- Able to understand, read and write English
Exclusion Criteria:
- Declined participation in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Supportive Care (MAP)
Participants complete MAP in-clinic over 60-90 minutes.
|
Ancillary studies
Ancillary studies
Complete MAP
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Enrollment Rate
Time Frame: Up to 1 year
|
To be calculated as the percent of eligible participants approached who agree to participate.
Will use one-sample tests of negative binomial probabilities and binomial proportions to compare rates of feasibility to hypothesized values.
Rates will be summarized using point estimates and 95% confidence intervals.
|
Up to 1 year
|
Participation Rate
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
To be calculated as the percent of participants who complete the study intervention among those enrolled.
Will use one-sample tests of negative binomial probabilities and binomial proportions to compare rates of feasibility to hypothesized values.
Rates will be summarized using point estimates and 95% confidence intervals.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Retention Rate
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
To be calculated as the proportion of participants who complete the study measures among those enrolled.
Will use one-sample tests of negative binomial probabilities and binomial proportions to compare rates of feasibility to hypothesized values.
Rates will be summarized using point estimates and 95% confidence intervals.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-reported Ratings of Intervention Acceptability
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Descriptive statistics will be used to summarize participant ratings of acceptability of intervention.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Measures of Autonomy Assessed by Index of Autonomous Functioning
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Each item in the scale ranges from 0-5, where 0=not at all true and 5=completely true.
Scale is a mean of these items and thus ranges from the same minimum of 0 to the same maximum of 5. A higher score represent higher degree of autonomy.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Self-efficacy for Managing Cancer - Chronic Disease Scale
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Scale is a mean of physical and emotional functional management of chronic disease.
Each of which runs from 1 (not at all confident) to 10 (totally confident).
A higher score represents a higher degree of confidence in self-efficacy.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Self-Efficacy for Managing Symptoms - Patient Reported Outcomes Measurement Information System (PROMIS) Short Form
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Overall score is based emotional and physical management of symptoms and is converted to a norm-based score that ranges from 0-100.
Higher score means more of construct or response of managing symptoms.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
PROMIS - Relatedness Assessed by Healing Encounters and Attitudes Lists (HEAL) Patient-Provider Connection
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
The overall score is based on participant's relatedness to interventionists and is converted to a norm-based score that ranges from 26.6-72.5.
Higher score on the HEAL measure means a higher degree of patient-provider connection as assessed by the patient.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Psychological Stress Assessed by Perceived Stress Scale
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Descriptive statistics (means, standard deviations) will be used to summarize proximal outcomes and change in health outcomes by assessment measure.
The primary interest will be in estimating the variance for use in planning future studies.
A 4-item questionnaires to assess participants' stress during the intervention at baseline and at two weeks with a difference of both time points.
Scoring scale is from 0-4 ( 0 - never and 4 - very often).
Scoring range is 0-16 with the higher score indicating higher stress.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Symptoms Assessed by Patient-Reported Outcomes Measurement Information System (PROMIS) Profile 29
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
PROMIS instruments contain a fixed number of items from seven PROMIS domains: depression; anxiety; physical function; pain interference; fatigue; sleep disturbance; and ability to participate in social roles and activities.
The PROMIS-29, a generic health-related quality of life survey, assesses each of the 7 PROMIS domains with 4 questions.
The questions are ranked on a 5-point Likert Scale.
There is also one 11-point rating scale for pain intensity.
Norm-based scores have been calculated for each domain on the PROMIS measures, so that a score of 50 represents the mean or average of the reference population.
A score of 60 means that the person is one standard deviation above the reference population.
On symptom oriented domains of PROMIS-29 (anxiety, depression, fatigue, pain interference, and sleep disturbance), higher scores represent worse symptomatology.
On the function oriented domains (physical functioning and social role) higher scores represent better functioning.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Health Behaviors Assessed by Items on Tobacco Use
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Descriptive statistics will be used to summarize proximal outcomes.
Participants were asked questions about their health behavior related to their past or present smoking behaviors (i.e.
packs per day, last time they smoked) in order to help improve upon the information received to offer support for future studies.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Qualitative Assessment of Feasibility With Semi-structured Interviews
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Will conduct a qualitative content analysis.
Qualitative data will be sent to an external vendor to be transcribed.
Two internal study team members will double-code at least 10% of coding of transcripts from the semi-structured interviews and resolve any disagreements to ensure that robust and unbiased results are achieved.
Will evaluate qualitative and quantitative analyses in a mixed-methods framework for consistency and discrepancies across all analyses to refine the protocol.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Qualitative Analysis of Systems Support Maps
Time Frame: Up to 1 year
|
The internal study team will work with collaborators through an iterative process to facilitate a qualitative content analysis of the large quantity of textual MAP data.
Will examine all qualitative analyses by urban-rural status as classified using Rural Urban Commuting Area Codes.
Qualitative results will be summarized by urban-rural status.
Will also compare MAP results by rural-urban status.
|
Up to 1 year
|
Health Behaviors Assessed by Items on Physical Activity
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Participant's ability to participate in physical activities (types of activities, intensity, etc.) will be assessed.
Descriptive statistics will be used to summarize proximal outcomes.
The primary interest will be in estimating the variance for use in planning future studies.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Health Behaviors Assessed by Items on Use of Complementary Health Approaches
Time Frame: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Participants will assess the use of complementary or alternative therapies use since first diagnosed with cancer.
Descriptive statistics will be used to summarize proximal outcomes.
The primary interest will be in estimating the variance for use in planning future studies.
|
Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later
|
Qualitative Assessment of Acceptability With Semi-structured Interviews
Time Frame: Up to 1 year
|
Will conduct a qualitative content analysis.
Qualitative data will be sent to an external vendor to be transcribed.
Two internal study team members will double-code at least 10% of coding of transcripts from the semi-structured interviews and resolve any disagreements to ensure that robust and unbiased results are achieved.
Will evaluate qualitative and quantitative analyses in a mixed-methods framework for consistency and discrepancies across all analyses to refine the protocol.
|
Up to 1 year
|
Qualitative Assessment of Changes in Outcomes With Semi-structured Interviews
Time Frame: Up to 1 year
|
Will conduct a qualitative content analysis.
Qualitative data will be sent to an external vendor to be transcribed.
Two internal study team members will double-code at least 10% of coding of transcripts from the semi-structured interviews and resolve any disagreements to ensure that robust and unbiased results are achieved.
Will evaluate qualitative and quantitative analyses in a mixed-methods framework for consistency and discrepancies across all analyses to refine the protocol.
|
Up to 1 year
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00048866
- P30CA012197 (U.S. NIH Grant/Contract)
- NCI-2018-00587 (REGISTRY: CTRP (Clinical Trial Reporting Program))
- CCCWFU 99118 (OTHER: Wake Forest University Health Sciences)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Survivor
-
University of New MexicoNew Mexico State University; University of New Mexico Cancer CenterCompleted
-
Ohio State University Comprehensive Cancer CenterCompletedCancer SurvivorUnited States
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Canadian Breast Cancer FoundationCompletedBreast Cancer Survivor | Pediatric Cancer SurvivorCanada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Oncology Nursing Society; Villanova UniversityCompletedChildhood Cancer SurvivorUnited States
-
Turku University HospitalLounais-Suomen SyöpäyhdistysNot yet recruiting
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnCancer SurvivorUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Auburn UniversityCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedCancer SurvivorUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); National Institute of Mental Health (NIMH)CompletedCancer SurvivorUnited States
Clinical Trials on Questionnaire Administration
-
Fondazione Don Carlo Gnocchi OnlusUnknown
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedHealth Status UnknownUnited States
-
Istanbul Aydın UniversityCompleted
-
Centre Oscar LambretCentre Hospitalier Universitaire de BesanconTerminated
-
Hospital Clínico Universitario de ValladolidRed Centinela Sanitaria de Castilla y León (RCSCYL); Centro Nacional de Gripe... and other collaboratorsRecruitingMigraine | Headache Disorders | Viral Infection | Influenza -Like Illness | Head PainSpain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBreast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | COVID-19 Infection | Hereditary Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Recurrent Plasma Cell Myeloma | Caregiver | Recurrent LeukemiaUnited States
-
I.M. Sechenov First Moscow State Medical UniversityAgency of Social Information St. PetersburgActive, not recruiting
-
I.M. Sechenov First Moscow State Medical UniversityActive, not recruitingShoulder ArthropathyRussian Federation
-
Karolinska University HospitalSahlgrenska University Hospital, Sweden; University Hospital, Linkoeping; Skane...Active, not recruitingQuality of Life | Vulvar CancerSweden